Lung Ultrasound Improves Outcome Prediction over Clinical Judgment in COVID-19 Patients Evaluated in the Emergency Department
- PMID: 35683419
- PMCID: PMC9181775
- DOI: 10.3390/jcm11113032
Lung Ultrasound Improves Outcome Prediction over Clinical Judgment in COVID-19 Patients Evaluated in the Emergency Department
Abstract
In the Emergency Department (ED), the decision to hospitalize or discharge COVID-19 patients is challenging. We assessed the utility of lung ultrasound (LUS), alone or in association with a clinical rule/score. This was a multicenter observational prospective study involving six EDs (NCT046291831). From October 2020 to January 2021, COVID-19 outpatients discharged from the ED based on clinical judgment were subjected to LUS and followed-up at 30 days. The primary clinical outcome was a composite of hospitalization or death. Within 393 COVID-19 patients, 35 (8.9%) reached the primary outcome. For outcome prognostication, LUS had a C-index of 0.76 (95%CI 0.68−0.84) and showed good performance and calibration. LUS-based classification provided significant differences in Kaplan−Meier curves, with a positive LUS leading to a hazard ratio of 4.33 (95%CI 1.95−9.61) for the primary outcome. The sensitivity and specificity of LUS for primary outcome occurrence were 74.3% (95%CI 59.8−88.8) and 74% (95%CI 69.5−78.6), respectively. The integration of LUS with a clinical score further increased sensitivity. In patients with a negative LUS, the primary outcome occurred in nine (3.3%) patients (p < 0.001 vs. unselected). The efficiency for rule-out was 69.7%. In unvaccinated ED patients with COVID-19, LUS improves prognostic stratification over clinical judgment alone and may support standardized disposition decisions.
Keywords: COVID-19; disposition; lung ultrasound; mortality; prognosis; score.
Conflict of interest statement
All authors state the absence of any potential financial and personal relationships with other people or organizations, even unrelated to the present study.
Figures
References
-
- Leira E.C., Russman A.N., Biller J., Brown D.L., Bushnell C.D., Caso V., Chamorro A., Creutzfeldt C.J., Cruz-Flores S., Elkind M.S.V., et al. Preserving stroke care during the COVID-19 pandemic: Potential issues and solutions. Neurology. 2020;95:124–133. doi: 10.1212/WNL.0000000000009713. - DOI - PMC - PubMed
-
- National Institutes of Health Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. [(accessed on 10 December 2021)]; Available online: https://www.covid19treatmentguidelines.nih.gov/ - PubMed
-
- Lim W.S., van der Eerden M.M., Laing R., Boersma W.G., Karalus N., Town G.I., Lewis S.A., Macfarlane J.T. Defining community acquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax. 2003;58:377–382. doi: 10.1136/thorax.58.5.377. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
